Phase I clinical study of personalized peptide vaccination combined with radiotherapy for advanced hepatocellular carcinoma

doi:10.3748/wjg.v23.i29.5395

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 23, Issue 29

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (7931)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-6) series, Tables (1-4) series.

Item

Count

PDF

560

WORD

284

HTML

4432

Figures (1-6)

208

Tables (1-4)

173

Sum=5657

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

769

Download

1118

Sum=1887

Aug 7, 2017 (publication date) through Nov 3, 2024

Times Cited of This Article

Times Cited (22)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Clinical Trials Study

World J Gastroenterol. Aug 7, 2017; 23(29): 5395-5404
Published online Aug 7, 2017. doi: 10.3748/wjg.v23.i29.5395

Full Size Figure Download Figure

Figure 4 Treatment outcome of patient 1. The liver mass within and out of the radiation field were both significantly decreased in size after treatment with a combination of radiotherapy and PPV-DC-CTL. AFP had a significant decline as well.

Citation: Shen J, Wang LF, Zou ZY, Kong WW, Yan J, Meng FY, Chen FJ, Du J, Shao J, Xu QP, Ren HZ, Li RT, Wei J, Qian XP, Liu BR. Phase I clinical study of personalized peptide vaccination combined with radiotherapy for advanced hepatocellular carcinoma. World J Gastroenterol 2017; 23(29): 5395-5404
URL: https://www.wjgnet.com/1007-9327/full/v23/i29/5395.htm
DOI: https://dx.doi.org/10.3748/wjg.v23.i29.5395